Université Paris-Sud (FR)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
148
Publications
1820
Citations
102578
i10-index
561
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Personalizing the treatment of women with early br... | 2013 | 3666 |
Toll-like receptor 4–dependent contribution of the... | 2007 | 2926 |
Response to Neoadjuvant Therapy and Long-Term Surv... | 2008 | 2872 |
Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Rece... | 2019 | 2451 |
3rd ESO–ESMO International Consensus Guidelines fo... | 2016 | 2057 |
AACR Project GENIE: Powering Precision Medicine th... | 2017 | 1952 |
Ribociclib as First-Line Therapy for HR-Positive, ... | 2016 | 1947 |
Trastuzumab Deruxtecan in Previously Treated HER2-... | 2019 | 1874 |
Tailoring therapies—improving the management of ea... | 2015 | 1819 |
Activation of the NLRP3 inflammasome in dendritic ... | 2009 | 1803 |
Fabrice André is a researcher with 1820 publications and 102578 citations. They are affiliated with Université Paris-Sud. Their research focuses on . With an h-index of 148, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Fabrice André and 250M+ other papers.
Citations per publication by year